Overview

• The deal values 23andMe’s assets at $305 million, topping Regeneron’s earlier $256 million bid
• The acquisition encompasses the company’s personal genome service, research operations and telehealth program
• TTAM Research Institute will honor existing privacy policies, notify customers before closing and form a Consumer Privacy Advisory Board within 90 days
• A coalition of 28 state attorneys general led by New York’s Letitia James has sued to block the transaction, arguing users did not consent to the transfer of their genetic information
• Since the March bankruptcy filing, about 15% of customers have asked to delete their genetic data over privacy concerns, and a court-appointed privacy ombudsman has questioned whether existing policies allow the sale